March 24, 2020 at 03:39PM Investigational New Drug (IND) or Device Exemption (IDE) Process (CBER)

An Investigational New Drug Application (IND) is a request for authorization from the Food and Drug Administration (FDA) to administer an investigational drug or biological product to humans.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2QIGEAH